human fibrinogen

Italy

Drugs containing this active substance

  • FIBRICLOTTE

    It is used to compensate for human fibrinogen deficiency and to prevent or treat bleeding in people with congenital fibrinogen deficiency (a hereditary disease that causes prolonged bleeding).

    Form: solution for injection/infusion, powder and solvent for preparation of

    Active substance Dosage
    human fibrinogen -

    ATC: B02BB01

    Manufacturer: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

  • FIBRYGA

    It is used to treat episodes of bleeding and for prevention during surgical procedures in people with a congenital fibrinogen deficiency. It is also used to supplement fibrinogen in patients presenting with severe and uncontrolled bleeding due to an acquired deficiency during surgery.

    Form: solution for injection/infusion, powder and solvent for preparation of

    Active substance Dosage
    human fibrinogen -

    ATC: B02BB01

    Manufacturer: OCTAPHARMA (IP) SPRL

  • TACHOSIL

    It is used in surgery to stop local bleeding and to seal the tissue surfaces of internal organs in adults and children (from 1 month of age onwards). In adults, it is also indicated in neurosurgery to seal the dura mater and prevent cerebrospinal fluid leaks.

    Form: patch, tissue adhesive

    Active substance Dosage
    human fibrinogen -
    human thrombin -

    ATC: B02BC30

    Manufacturer: CORZA MEDICAL GMBH